We are happy to announce that we are LegitScript Certified.

Patient Resources

  1. Home
  2. Patient Resources
  3. Health Videos

Get Healthy!

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Multiple SclerosisBrain
HealthDay
Health News is provided as a service to Powell Drug site users by HealthDay. Powell Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags

Multiple SclerosisBrain